U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that the x-ray was discovered purely by accident? When German physicist Wilhelm Konrad von Roentgen was experimenting with cathode rays in 1895, he put an activated Crookes tube in a book and went out to lunch. When he returned, he discovered that a key that had also been placed in the book showed up as an image on the developed film!

Newsletter  PatentStorm News

Make the Most of PatentStorm

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest patents by subscribing to an RSS feed.

Got questions? Ask a Patent Expert!

Registered users: Manage your profile, comments and alerts.

 

US Patent 6855721 - Methods and compositions for alleviating stuttering

US Patent Issued on February 15, 2005
Estimated Patent Expiration Date: Icon_subject July 28, 2020Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
loading...


View Patent Images (PDF)
(Registered users only)

Abstract

Methods of treating stuttering include treating people with gamma-aminobutyric acid (GABA) receptor modulators, including cyclopyrrolones. A second active agent may be used with GABA receptor modulators. Active enantiomers, active metabolites, and pharmaceutically acceptable salts of gamma-aminobutyric acid receptor modulators, including cyclopyrrolones, are acceptable components of the compositions. The cyclopyrrolone class of modulators includes pagoclone, suriclone, zopiclone, 2-(7-chloro-2-naphthyridin-1,8-yl)-3-(5-methyl-2-oxohexyl)isoindolin-1-one, 2-(7-chloro-2-naphthyridin-1,8-yl)isoindolin-1-yl-4-acetamidobutyrate, and 2-(7-chloro-1,8-naphthyridin-2y1)-3-(5-methyl-5-hydroxy-2-oxohexyl)-1-isoindolinone.

Other References

  • Sandyk, International Journal of Neuroscience, 1995, 83(1-2): 81-92.*
  • Doble et al. “RP 59037 and RP 60503: Anxiolytic Cyclopyrrolone Derivatives with low sedative ptential. Interaction with the gamma-amminobutyric AcidA/ Benzodiazepine receptor complex and behavorial effects in the rode” J Pharmacol Exp Ther 266(3):1213-26.*
  • Sandyk,Medline Abstract AN:96357641 of International Journal of neuroscience, 1995, 83(1-2):81-92.*
  • Brady et al. 1991 “The Pharmacology of Stuttering: A Critical Review” Am J Psychiatry 148:1309-1316.
  • Wells et al. 1971 “Control Trial of the Treatment of 36 Stutterers” Brit. J. Psychiat. 119: 603-4.
  • Rentschler et al. 1984 “The Onset of Stuttering Following Drug Overdose” J. Fluency Disord. 9: 265-284.
  • Brewerton et al. 1996 “Stuttering With Sertaline” J Clin Psychiatry 57(2):90-1.
  • Vink et al. 1992 “Clonidine and stuttering” Am J. Psychiatry 149(5):717-8.
  • Costa 1992 “Antidepressants and the treatment of stuttering” Am J Psychiatry 149(9):1281.
  • Christensen et al. 1996 “A Case of Sertraline-Induced Stuttering” J Clin Psychopharmacol 16(1):92-93.
  • Makela et al. 1996 “Reply [to Christensen et al.]” J Clin Psychopharmacol 16(1):93.
  • Brady 1992 “Dr. Brady Replies [to Vink et al.]” Am J. Psychiatry 149(56):718.
  • Brady 1992 “Dr. Brady Replies [to Costa]” Am J. Psychiatry 149(9):1281.
  • Stager et al. 1995 “Fluency Changes in Persons Who Stutter Following a Double Blind Trial of Clomipramine and Desipramine” J Speech Hear Res. 38:516-25.
  • Schreiber et al. 1997 “Paroxetine for secondary stuttering: further interaction of serotonin and dopamine” J Nerv Ment Dis. 185(7):465-7.
  • Fernandez et al. 1995 “Clinical Pharmacokinetics of Zopiclone”; Clin Pharmacokinet, 29(6): 431-41.
  • Doble et al. 1993 “RP 59037 and RP 60503: Anxiolytic Cyclopyrrolone Derivatives with Low Sedative Potential. Interaction with the γ-Aminobutyric AcidA/Benzodiazepine Receptor Complex and Behavorial Effects in the Rodent” J Pharmacol Exp Ther. 266(3):1213-26.
  • Korpi et al. 1997“GABAA-receptor Subtypes: Clinical Efficacy and Selectivity of Benzodiazepine Site Ligands” Annals Med 29:275-282; Erratum 1997 Annals Med 29: 275-82.
  • Kiziltan et al. 1996 “Stuttering May Be a Type of Action Dystonia” Movement Disorders 11(3): 278-282.
  • Swinyard 1990 “Sedatives and Hypnotics”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1057-1071.
  • Di Santo 1990 “Bioavailability and Bioequivalency Testing”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1451-1458.
  • Vadas 1990 “Stability of Pharmaceutical Products”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1504-1512.
  • Nairn 1990 “Solutions, Emulsions, Suspensions and Extracts”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1519-1544.
  • Avis 1990 “Parenteral Preparations”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1545-1569.
  • O'Connor et al. 1990 “Powders”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1615-1632.
  • Rudnic et al. 1990 “Oral Solid Dosage Forms”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1633-1665.
  • Porter 1990 “Coating of Pharmaceutical Dosage Forms”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1666-1675.
  • Longer et al. 1990 “Sustained-Released Drug Delivery Systems”, Remington's Pharmaceutical Sciences, Gennaro, A.R., 18th Edition, Mack Publishing Co., Easton, PA, pp. 1676-1693.
  • Brady 1998 “Drug-Induced Stuttering: A Review of the Literature”, J. Clin. Psychopharmacol. 18(1):50-4.
  • Elliott et al. 1985 “A Case Report of Alprazolam Induced Stuttering”, J. Clin. Psychopharmacol. 5(3):159-60.

Inventors

Assignee

Application

No. 09628803 filed on 07/28/2000

US Classes:

514/300, Plural hetero atoms in the bicyclo ring system424/468, Sustained or differential release type424/419, Natural or synthetic resin424/488, Polysaccharides (e.g., cellulose, etc.)424/497, Containing solid synthetic polymers424/480, Cellulose or derivative546/122, The other cyclo in the bicyclo ring system is also six-membered (e.g., naphthyridines, etc.)210/198.2Chromatography

Field of Search

514/300, Plural hetero atoms in the bicyclo ring system514/310Nitrogen, other than as nitro or nitroso, attached directly to the isoquinoline ring system by nonionic bonding

Examiners

Primary: Padmanabhan, Sreeni
Assistant: Hui, San-Ming

Attorney, Agent or Firm

US Patent References

4401663, Novel sulfonamide derivatives
Issued on: 08/30/1983
Inventor: Buckwalter ,   et al.
4788055, Resinate sustained release dextromethorphan composition
Issued on: 11/29/1988
Inventor: Fischer ,   et al.
4816264, Sustained release formulations
Issued on: 03/28/1989
Inventor: Phillips ,   et al.
4828836, Controlled release pharmaceutical composition
Issued on: 05/09/1989
Inventor: Elger ,   et al.
4834965, Controlled release pharmaceutical composition
Issued on: 05/30/1989
Inventor: Martani ,   et al.
4834985, Controlled release pharmaceutical composition
Issued on: 05/30/1989
Inventor: Elger ,   et al.
4960779, Pyrrole derivatives, and pharmaceutical compositions which contain them and pharmacological methods of use
Issued on: 10/02/1990
Inventor: Bourzat, et al.
4996047, Sustained release drug-resin complexes
Issued on: 02/26/1991
Inventor: Kelleher, et al.
5071646, Pharmaceutical ion exchange resin composition
Issued on: 12/10/1991
Inventor: Malkowska, et al.
5133974, Extended release pharmaceutical formulations
Issued on: 07/28/1992
Inventor: Paradissis, et al.
5494915, Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same
Issued on: 02/27/1996
Inventor: Barreau, et al.
5599936, Isoindolinone derivative, preparation thereof and pharmaceutical compositions containing same
Issued on: 02/04/1997
Inventor: Barreau, et al.
5676831Isoindolinone derivative, preparation thereof and pharmaceutical compositions containing same
Issued on: 10/14/1997
Inventor: Barreau, et al.

Foreign Patent References

  • 9800727 DK 05/01/1998

International Class

A61K031/44

Comments

No comments for this page
 
 
Forgot password?
Register here